Analyzing Vaccine Trials in Epidemics With Mild and Asymptomatic Infection

Vaccine efficacy against susceptibility to infection (VE(S)), regardless of symptoms, is an important endpoint of vaccine trials for pathogens with a high proportion of asymptomatic infection, because such infections may contribute to onward transmission and long-term sequelae, such as congenital Zi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kahn, Rebecca, Hitchings, Matt, Wang, Rui, Bellan, Steven E, Lipsitch, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Practice of Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357804/
https://www.ncbi.nlm.nih.gov/pubmed/30329134
http://dx.doi.org/10.1093/aje/kwy239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357804/
https://www.ncbi.nlm.nih.gov/pubmed/30329134
http://dx.doi.org/10.1093/aje/kwy239

Ejemplares similares